IX. Concluding l~emarks

I. Introduction
A LTHOUGH THE IMPORTANCE of DNA-repair pathways in protecting the genome from damage caused by endogenous and exogenous DNA-damaging agents (40, 44, 60) has long been recognized, the role of redox regulation in these pathways is a relatively recent discovery. In writing this revie'~', vve attempted to guide the reader through general as well as specific aspects of DNA repair and redox regulation, focusing u ltimately on the connection beh-veen the h-vo. We begin vvith an overview of DNA-repair pathways leading to a more in-depth discussion of one specific DNA-repair pathway, the base excision repair (BER) pathway. We focus on the BER pathway, which is responsible for the repair of DNA damage caused by oxidation, alkylation, and ionizing radiation, and specifically on apurinic/ apyrimidinic endonuclease 1 (APEl ), the only DNA-repair protein currently known to serve a dual role as a repair enzyme and a redox factor. In its role as a redox factor, APEl modifies downstream trai1scription factors such as AP-1, NF-KB, CREB, p53, and others, and thereby indirectly alters the activity of other DNA-repair pathways. To p ut the redox activity of APEl in perspective, we provide an overvievv of general redox systems as well as an in-depth discussion of the redox activity of APEl. Finally, in considering the impact of redox regulation of DNA repair to human health, we discuss the modulation of the redox activity of APEl by small molecules and the potential for chemotherapeutic development targeting redox regulation of DNA repair.
II. DNA-Repair Pathways
The genome of eukaryotic cells is constantly under attack from both endogenous and exogenous DNA-damaging agents. DNA damage resulting from endogenous agents includes oxidation by reactive oxygen species (ROS) generated from normal 1netabolic processes, alkylation by agents such as 5-adenosylmethionine, adduct fonnation resulting from attack by reactive carbonyl species fonned during lipid peroxidation, hydrolytic depurination leading to the formation of abasic sites, or deamination of bases, primarily cytidine, and to a lesser extent, adenine (44). Exogenous agents include envirorunental insults (chemicals, carcinogens, UV light), che1notherapeutic agents, and radiation dan1age (40, 60). Failure to repair DNA damage in both postmitotic and mitotic (110, 160) . However, we have evolved a series of DNArepair pathways to correct the damage, incl_uding ~~ect repa~ (DR), base-excision repair (BER), nucleot1de-exas1on_ re~arr (NER), mis ma tch repair (MMR), homologous recomb1n~ti on (HR), and nonhomologous end joining (NHEJ) (85, 86) (Fig.~) .
The number of DNA-repair proteins and factors involved 111 the cellular response to DNA damage keeps growing as m ore and more information is obtained, not only on the DNA repair enzymes involved in each path,.vay, but a lso on the regulatory networks that are induced by persis~ence o_f DNA darnage in the cell (182) . Dis tinct DNA damage IS re parred by the different pathways and mechanisms. Overlap and inte_r-action between the various pathways and some overlap In mechanisn1s occur. For example, 0 6 -n1e thylguanine can be removed directly by 0 6 -m ethylguanine-DNA methyltransferase (MGMT o r AGl) in DR, but if this pathway is not successful, the 0 6 mG mispairs and is recognized by the MMR pathway (59). Similarly, oxidative DNA dam~ge is ~epaired mainly by BER, but som e repair by NER also lS possible (53). Single-sh·and DNA breaks (SSBs) unrepaired by BER lead to d ouble-strand breaks (DSBs), which may be repaired by HR, and HR can also repair DNA DSBs that NHEJ pathways fa il to process (49). Interaction of different DNA-repair pathways and mechanisms provides the most efficient defense for the cell genome, whereas reduced repair capacity ca:' lead . to genomic instability. A number of diseases are as~oc1ated with defects in DNA repair, including xeroderma p1gmentosum , Cockayne syndro1ne, trido thiodys trophy, Werner syndrome, and Bloom syndro me (118, 162) . The reader is directed to recent comprehensive reviews for more specific information on each DNA-repair pathway (47, 111, 144, 145, 150, 157, 174) .
For updated information on the individual repair proteU:-S, the following link m ay prove i.1seful: http://W\.vw_.cgal.1cnet/ DNA_Repair_Genes.html (182) . What follows is an overview of ONA-repair pathways necessary to provide a context for understanding the role of redox regulation in DNA repair.
A. Mammalian direct repair: d'-alkylguanine-DNA methyltransferase or d'-methylguanine-DNA methyltransferase
This type of repair in mammals is tern1ed direct reversal because the damaged base is repaired through removal of the alteration to the base instead of ren1oval of the d a1naged base. It is i.mique in this sense and probably is the most efficient mechanism of repair (105) . The protein that carries out this reaction, the AGT protein, removes alkyl groups through direct transfer from the 0 6 position of guanine and to a lesser extent from the 0 4 position from thymine to the protein, leaving a guanine o r thymine in DNA and ina c~va ted protein. This L5 a stoichiometric reaction, as one protem removes one a lkyl group and is then degraded. It is essential to repair 0 6 -meG adduc ts, as they cause errors by mispairing with thymine during replication, leading to G:C to A:T transitions or a strand break.
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B. Base-excision repair
BER is responsible for the repair of DNA damage arising fro1 n alkylation, d eamination, or oxidation of bases (8, 40, 
50).
Alkylation of bases arises from exposi.rre to either endogenous agents such as S-adenosylmethionine or exogen~us agents, including environmental and chemotherapeu tic agents, w hereas deamination of cytidines and adenines occurs spontaneously. Oxidative damage can result from ROS generated by normal cellular processes, in a ddition to envirorunenta l or chemotherapeutic agents. BER is initiated by the removal of the damaged base through enzymes called DNA glycosylases, which specifically recognize severa l different types of base damage. Glycosylases are of two types, monofunctional and bifunctionaL Monofunctional glycosylases (e.g., N-methyl purine DNA glycosylase (MPG or AAG)] excise the d~a~ed base to generate an a purinic/ apyrimidinic (AP) or abas1c site, which is acted on by the multifunctional AP endonuclease, APEl. Bi functional glycosylases such as human 8-oxoguanine ONA glycosylase (hOGGl), human endonuclease VIII-like DNA glycosylase (NEILl-3), and E. coli endonucl~ase III (NTH) glycosylase have an additional A!' lyase function (~6, 43) that excises the damaged base and rucks the phosphod1e-s ter backbone 3' to the AP site. The resulting AP site is processed by APE1, which hydrolyzes the phosphodiester backbone immediately 5' to the AP site, creating 3' OH and 5' deoxyribose phosphate (5' dRP) te rmini. At this s tage, repair can proceed by two pathways: the short-patch BEl~ (SP-BEl~) pathway and the long-patch BER (LP-BER)_ p~th.way. APEl is responsible for 95°/o of the endonuclease act1v1ty 1n the cell a nd is a critical part of both the short-patch and the long-patch BER pathway (45, 46). SP-BER repa irs normal AP sites. DNA polymerase f3 (pol /3) removes the 5' dRP moiety by its dRPase activity and u ses the 3' OH terminus to insert the correct b~s~. The nick is ligated by DNA ligase ill/ XRCCl, and reparr lS completed. The LP-BER pathway preferentially repairs oxidized and reduced AP sites and is a minor branch of the BER pathway. A segment or fl ap of three to eight n_uc leo~des Sttrrounding the AP site is displaced, followed by insertion of t~e correct nucleotides by DNA polymerase b, s, or {3, along with proliferating cell nuclear antigen (PCNA) and replication factor-C (RF-C). After resynthesis, flap endonuclease 1 (FENl) removes the displaced s trand, and DNA ligase T, or the DNA ligase ill/ XRCCl complex ligates the nick. APEl i..r; the only AP endonuclease that performs these functions in the BER, and as such, is a key player in the BER process. APEl also coordinates recruitment of other DNA-repair pro teins involved in BER throu gh a comp lex network of direct pr~tei~-protein inter~c tions and indirect interactions, as shown in Fig. 2 . N o effective backup to APEl activity exists in the cell'. as is disc~. in more detail later, including its other tna1or redox-s1gnaling function.
C. Nucleotide-excision repair
The NER pathway is responsible for repairing large adducts such as ultraviolet-light-induced cyclobutane pyrimid ine dimers, add ucts induced by polycyclic aroma tic hydrocarbons, and other bulky DNA lesions _induced. by cross-linking agents and base-damaging che1mca~ carci_no-gens. Numerous proteins are required to co~plet~ ~ER: More than 25 proteins subpathways; global genome repair (GGI~) and transcriptioncoupled repair (TCR), depending on the complexes that initiate repair (8, 63) . TCR is initiated ""hen RNA polymerase II (RNA Pol TI) stalls at sites of DNA damage. TCR-specific factors, including the Cockayne syndrome proteins, CSA and CSB, are recruited at the site of transcription arrest, follo;ved by removal of the lesion by NER enzymes. In contrast, the heterodirner XPC/ HR23B appears to be the major damagerecognition factor in hun1an cells. The UV-DNA damagebinding protein UV-DDB is additionally required for NER of UV-induced cyclobutane pyrimidine d imers. After recognition, both TCR and GGR use the same proteins to repair the damaged DNA. The transcription-factor ITH (TFIIH) complex is recruited to the site of DNA damage, including its component heli.cases, XPB and XPD (xerodem1a p igmentosum complementary group B and D proteins) that unwind the DNA strand on either side of the DNA damage. XPA and RPA (replication protein A) stabilize the exposed single-strand DNA followed by cleavage of the 27-to 30-nucleotide fragment 3' and 5' of the lesion by endonucleases XPG and ERCCl/XPFl/XPF. The resulting gap is filled in by the DNA polymerases{> ore, along with PCNA, RPA, and replication factor C (RFC) by using the undamaged strand as a template.
D. Mismatch repair
In a broad definition, MMR is responsible for the recognition and repair of single mismatches or misaligned short nucleotide repeats. Mismatches can be endogenously caused by spontaneous deamination of 5-methylcytosine to thy1nine, resulting in a guanine-to-thyinine mismatch, damage to the cellular nucleotide pool, cytosine deamination to uracil, resulting in a guanine-to-uracil mismatch, or incorrect incorporation by DNA polymerase. A complex of MSH2 and MSH6 recognizes the mismatd1 and initiates the pathway. Various conwi.nations of MSH2 and either MSH3 or MSH6 are fom1ed, which specify the type of mismatch recognized. For example, when MSH2 is paired with MSH6, it recognizes both insertion-deletion mispairs and single-base mismatches, whereas \·vhen it is paired with MSH3, the complex recognizes insertion-deletion m ispairs. After recognition, MSH proteins recruit MLHl and its binding partners, post-meioticsegregation increased-I protein (PMSl) and PMS2. An exonuclease removes the DNA lesion, a DNA polymerase synthesizes a new strand, and finally, a DNA ligase completes the repair. This has been previously reviewed (104, 126) .
E. Nonhomologous DNA end-joining and homologous recombination
NHEJ is the main repai r pathway for DSBs in mammalian cellc;. DNA DSBs may be caused by ionizing radiation (IR), chemotherapeutic drugs, cleavage during V (D) J-recombination, meiotic recombi11ation, or the collapse of replication forks. DSBs are the most severe fo1m of DNA dan1age and endanger genomic stability by coordinating deletion or translocation or both of chromosomal DNA. Proteins induding, but not limited to, Ku 70, Ku 80, DNA ligase IV, and XRCC4 are part of the NHEJ-repair pathway. The Ku proteins bind to the ends of broken DNA and, as a complex with DNAPKs (DNA-dependent kinase catalytic sub\.nut), interact '~1ith DNA li.gase IV ai1d XRCC4 to repair DNA through the NHEJ pathway. DNA ligase IV and XRCC4 function in a complex to ligate the nick and to complete repair (34) . Discovery of neV\' proteins involved in NHEJ includes Metnase or SETMAR (117) , which has been shown to interact with DNA ligase lV and to enhance the efficiency and accuracy of NHEJ (92) .
Homologous recombination (HR) also is i11volved in repairing DNA DSBs. HR is initiated through the DSB recognition by ATM (ataxia telangiectasia-mutated protein), which phosphorylates multiple downstream proteins. DSBs ssDNA ends, allowing the RAD52/ RAD54 complex to join and fom1 larger co1nplexes with BLM and WRN proteins. These large protein complexes at the strand break direct pairing of the p rocessed DNA with a homologous region on the sister chromatid and initiate strand exchange. This was previously reviewed in detail (167) .
Ill. General Redox Systems
In living systems, two systems are primarily responsible for general reduction-oxidation (redox) regulation, the thioredoxin (TRX) and glutaredoxin/ glutathione (GRX/ GSH) systems. They maintain the redox cellular homeostasis as '~'ell as redox regulate several cellular processes through a thiolredox mechanic;m (91, 142) . Thiol-based redox mechanisms rely on the special properties of Cys residues, which can adopt 10 different sulfur oxidation states from +6 to -2 (the fully Components of the thioredoxin system include thioredoxin (TRX), NADPH, and thioredoxin reductase (TR) (90, 100) . Thioredoxins (TRXs) comprise a large family of structurally conserved proteins that serve as general protein disulfide oxidoreductases and can reduce disulfide bonds in a va1iety of proteins through a thiol/ disulfide exchange mechanism (143) . Oxidized thioredoxin is then reduced by thioredoxin reductase, a flavoprotein containing a selenocysteine, in a reaction involving NADPH.
Thioredoxins (Tl{)(s) share a similar active-site motif Cys-X-X-Cys and a common structural motif, kno,vn as the TRX fold (91, 120, 153) , 'vhich consists of a four-stranded /J-sheet surrounded by three a-helices (Fig. 4) . The active-site motif is located on the loop connecting /J-sheet 1 and a-helix 1. The Nterminal Cys residue in the active site is surface exposed and has a lo,.v pK. value; for example, Cys32 in human TRX has an estimated pK. of 6.3 (61), whereas the C-terminal Cys is buried in the molecule and has a much higher pK., value. It has been proposed that the low pK., value of the N-terminal Cys arises from the partial positive charge from the dipole mon1ent associated with et.-helix 2 (88), or alternatively, may be due to its hydrogen bond to the C-term.inal Cys (181) . The nucleophilicity of the thiolate group of the Cys is increased by the low pK •. The proposed reaction mechanic;m of disulfide reduction by thioredoxin is as follows: the N-term.inal cysteine thiolate of TRX acts as a nucleophile and attacks the target disulfide, resulting in a transient mixed disulfide inte1me-diate, vvhich is, in turn, reduced by the C-te1minal activesite Cys resid ue, generating a dithiol in the target p rotein and a disulfide in thioredoxin (91, 108, 120) (Fig. 3) . The resulting disulfide in the active site of TRX can be reduced by Tl~ with electrons from NADPH, completing the catalytic cycle.
The mechanism by ,.vhich TR reduces TRX back to the dithiol involves the fonnation of a selenylsulfide in the active site of TR (100), as shown in Fig. 4 . A second redox active site located in the other subunit of the dimeric TI~ contains two thiols that reduce the selenylsulfide back to a thiol and selenol, with the resultant formation of a disulfide bond. This disul fide is red uced by electron transfer from FADH 21 and the resulting FAD is then reduced by electron transfer from NADPH (100).
B. The glutaredoxin/ glutathione system
The g lutaredoxin system is composed of NADPH, the flavoprotein glutathione reductase, g lutathione, and glutaredoxin (54, 90, 121) . This system also works through a cascade of disulfide oxidation and reduction. Glutaredoxins (GRXs) are small redox enzymes of ~ 100 amino acid residues, which use gluta thione as a cofactor. Structurally glutaredoxins are very similar to thioredoxins, retaining the same fold and active sites. However, the active site of GRXs includes Cys-X-X-Cys or Cys-X-X-Ser. By using a similar reactive mechanism, GRXs catalyze the reversible reduction of substra te protein disulfides, resulting in oxidation of the GRXs (Fig. 5) . Oxidized GRXs are reduced nonenzymatically by g lutathione (glutamyl-cysteinyl-glycine,GSH), and then the oxidized g lutathionine disulfide (GSSG) is reduced by glutathione reductase at the expense of NADPH (121).
C. Roles of general redox systems
Tlu·ough a thiol/ disulfide exchange mechanism, thioredoxin and gluta redoxin systems maintain a red ucing intra-H. cellular redox state, which is an important metabolic variable, influencing many aspects of cell function, like growth, apoptosis, and reductive biosynthesis. Tn addi tion, by redox signaling, they control the activat ion of a number of transcrip tion factors and hence regulate a broad range of cellular functions (11, 153, 192) . The two redox systems physiologically play many roles in different organisms and, conversely, are also pathophysiologic factors for a va1iety of hun1an diseases, including cancer, viral disease, Alzheimer's disease, and others (7, 12, 33, 154) , and hence serve as vital drug targets for cancer therapy and other disease treatments (20, 39, 122, 123, 141) . Although the thioredoxin system and glutaredoxin syste1n share a number of ftu1ctions, they are not just simple duplicate systems; TRX and GRX act on different substrates (54, 121). TRX but not GRX, for example, has been implicated in the reducti on of APE1 (6, 83, 94, 170) .
The remainder of our discussion on redox factors focuses on APE1, which is the only DNA-repair protein kno,-vn also to have a role in redox regulation affecting the expression of a number of other DNA-repair proteins.
IV. The Redox Activity of APE1
In a search to identify the nuclear factor responsible for reducing the transcription factor AP-1., a factor termed redox effector factor 1, Ref-1, '~'as identified (184, 187) . Since this initial dic;covery, APEl (Ref-1) has been reported to reduce a number of other ilnportant transcription factors, includil1g
NF-KB, HIF-la, p53, PAX, and others (35, 48, 83, 84, 112, 169, 175) (Fig. 6) . And, as discussed below, the redox activity of APEl plays an important ro le in regulating the expression of a large number of DNA-repair proteins.
A. Evolution of the redox function of APE1
Although APE1 is reported to have distinct redox and repair domains (186) located "vithin the N-and C-term.inal regions of the protein, respectively, these functional domains do not correspond to independently folded domains within the proteil1 (i.e., structural domains). Furthermore, the repair and redox activities do not appear to be coordinated wi thin human APEl, and '"'hereas the AP endonuclease activi ty of APEl is conserved from bacteria to humans, the redox function is unique to mammals. Tl1us, as shown in 
FIG. S. Reduction of oxidized p roteins
by glutaredoxin/ glutathione (GRX/ GSH ). Through a mechanism similar to that used by TRX, GRX also forms a mixed-disulfide intennediate '"'ith an oxidized protein. This disulfide is resolved through involvement of a second Cys residue of the CXXC motif in GRX, resulting in reduction of the protein and formation of a disulfide bond in GRX. GSH directly reduces GRX again through a disulfide-exchange mechanism and is itself reduced by glutathione reductase.
[Adapted from Lillig et al. (121) .] -A-C-T-T-~- but also very similar endonudease active sites (Fig. 8 ). The sequence identity between APEl and exonuclease III is 27.7%. The most obvious structural difference between human APEl and exonuclease III is an additional 62 N-terminal residues found only in APEl (Fig. 7) . Within this N-terminal region of APEl is a nuclear localization sequence. However, addition of N-tenninal residues alone does not confer redox activity; zebra fish APE includes a similar N-terminal addition ( Fig. 9 ) but lacks redox activity (68). So the question then becomes, what is required for the redox activity of human APEl (hAPEl)? This continues to be a source of controversy in the literature. Of the seven Cys residues present in hAPEl, Cys 65 1.vas identified as the critical residue required for redox activity tlu·ough analysis of single Cys-to-Ala substitutions within APEl (see Fig. 10 ) (178) . Investigation of the role of Cys residues \.vithin APEl was based on the finding that a Cys residue within the DNA-binding domain of the transcription factor c-Jun was subject to oxidation, leading to loss of DNA bindings and \.vas reduced by APEl (2, 184, 187) . Subsequently, the crystal structure of human APEl was reported (70), revealing that Cys 65, a residue unique to mammalian sequences, is a buried residue located on the first fJ strand in the fold, which is part of a fJ sheet in the core of the protein ( Although the zebra fish APE (PDB identifier, 203C, light gray) also includes an extended N-terminus similar to that found in the human APEl (PDB identifier, 203H, dark gray), it does not have redox activity. As sho~vn in these ribbon renderings, the zebrafish and human enzymes are structurally very similar, including the N-terminal residues. Conserved Cys residues, including 93, 99, 208, 296, and 310, are shown in black stick rende1ings for the human enzyme.
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FIG. 10. Positions of Cys residues within APEl. The
human APEl (PDB identifier, lBIX, gray ribbon rendering) includes seven Cys residues (black sticks), whose positions relative to the active-site His 309 are sho~vn. None of the Cys residues is appropriately positioned to form a disulfide bond, and the redox-critical Cys residue, Cys 65, is a buried residue located in the first P strand of the APEl fold. 58, the structure and chemical environment is highly conserved (68). In contrast, residues in the vicinity of Val 4 in the E. coli enzyme exonuclease TIT are not similar to those found in the vertebrate APEs.
The report of a viable C64A knockin mouse and data \<vi thin challenged the validity of a role for Cys 65 in the redox activity of APEl (148) . However, \<Ve note that the mouse knockin study does not directly address the role of Cys 65 (64 in mouse) in the redox activity, but rather suggests that Cys 65 is not essential for the development of the mouse, potentially confirming that redox systems are red1mdant. In an effort to clarify this issue, we substituted Thr 58 with Cys in zAPE, thereby conferring redox activity to the enzyme, as measured both in EMSA redox and transactivation redox assays (68). To date, the preponderance of evidence supports a role for Cys 65 in the red ox activity of hA PE1 . Thus, we conclude that evolution of redox activity in hAPEl is coincident with the appearance of Cys 65 in mammalian sequences.
B. Comparison of APE1 with other redox factors
ln contrast to molecules such as TRX and GIV<, which maintain the general redox status of the cell, APEI does not contain t'~'O Cys resid ues within a C-X-X-C motif. Thus, the mechanism by which APE1 reduces transcription factors is likely to differ from that of thioredoxin or glutaredoxins. In the crystal structures reported to date of APEI, no disulfide bonds are present, and the only Cys residue reported to be absolutely required for redox activity is Cys 65, which is a buried residue. The Cys residues positioned closest to one Local unfolding of C-terminus in oxidized PRX C-terminal region in reduced PRX "'...
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FIG. 11. Redox mechanism of peroxiredoxin (PRX) involves local unfolding. Peroxiredoxin is the enzyme responsible for detoxification of hydrogen peroxide. In a mechanism dissimilar to that used by TRX or GRX, PRX has two Cys residues, one located in each subunit of the dimeric structure, which participate in the reduction of hydrogen peroxide, leading to the for1nation of disulfide bond in PRX. Reduced PRXII (PDB identifier, lQMV) is shown in the left panel as a ribbon rendering with one subunit in light gray, the second in dark gray, and Cys residues in black. Tn the right panel, the oxidized PRXI (PDB identifier, 1QQ2) is rendered similarly. Unfolding of the C-te:minus of the dark-gray subunit allows the formation of a disulfide bond between the Cys residues that are located ~9 A apart in the reduced form of the protein.
another are 93 and 208, but their respective S atoms are ~3.5
A apart, too far apart to fom1 a disulfide bond, which is typically ~2.2 A in length. Further, these residues are buried in the core of the protein and are not accessible. The solventaccessible Cys residues include 99 and 138; however, these residues are not in close proximity to one another and would not be expected to interact to form a disulfide bond. Furthe1more, substitution of Ala for either Cys 99or138 has no effect on redox activity (178) . Before the determination of the crystal structure of APEl, it was proposed that Cys 65 and 93 form a disulfide bond (178) . Given the respective locations of (Fig. 10) , a substantial conformational change in the structure of the protein would be required for a disulfide bond to form between these residues.
Another group of redox proteins, peroxiredoxins, are responsible for sensing hydrogen peroxide in the cell and serve as catalysts to detoxify this extremely reactive molecule (87) . These enzymes are dissimilar to thioredoxin-or glutaredoxintype molecules in that they lack a C-X-X-C n1otif, but they do include two Cys residues that are required for activity (183) .
These Cys residues are located ~9 A from one another in the fully folded dimeric stn1cture (Fig. 11) ; one Cys from each monomer forms the active site (183) . The nucleophilic thiolate is sequestered before a local unfolding event near the dimer interface. The resolving thiolate is located near the C-terminus of the molecule and, on local unfolding, is placed in close proximity to the nucleophilic thiolate (183) (Fig. 11 ) . Peroxiredoxins reduce hydrogen peroxide and not other proteins (87) , but on overoxidation to the sulfenic or sulfinic acid state, are themselves reduced by sulfiredoxin (29, 177) . The requirement for local unfolding for peroxiredoxin to complete its catalytic cycle in the detoxification of hydrogen peroxide is very interesting and may be a general mechanism used by other redox factors. Although APEl does not include two Cys residues positioned similarly to those found in peroxiredoxin, the possibility remains that a conformational change or local unfolding event may result in more favorable positioning of Cys residues. An interesting similarity bet\~reen APEl and peroxiredoxin is the proximity of a C ys residue to a terminus; in the case of hAPEl, Cys 65 is located relatively close to the N-terminus of the protein; it is located \~rithin the first secondary stn1ctural element (a /3 strand) in the fold (Fig. 7) . Tn summary, we conclude that hAPEl is unique as a redox factor, having evolved this additional function while maintaining its essential base-excision repair activity.
C. Mechanism of redox regulation by APE1
Although a role for Cys 65 in the redox activity of hAPEl has been established (68, 178), a detailed mec11anismhas yet to be elucidated. Jt is possible that another as-yet-unidentified Cys residue in APEl is involved in the redox activity. In this case, after the formation of a mixed disulfide intermediate beh.veen Al)El and a transcription factor, a resolving Cys would serve to restore the thiolates in the transcription factor. As noted earlier, this interaction would likely involve a different conformation of hAPE1 than has been reported in the crystal structures to date (17, 68, 70, 139) . Alternatively, a residue other than Cys might be involved in the redox activity, perhaps a Ser residue, as found in some glutaredoxins. A similar mechanism would be proposed in this case, although involvement of a Ser residue ;vould require a significant reduction in its pK •. As the stoichiometry of the relevant redox complex has yet to be established, it is possible that more than one APEl molecule is involved in the reduction of transcription factors. In this case, a Cys or Ser from a second molecule of APEl may serve as the resolving thiolate, again, in a mechanisn1 similar to that p roposed for thioredoxin. As this problem is of considerable interest, we are actively investigating the mechanism of redox regulation by hAPE1.
V. Transcription Factors Regulated by the Redox Activity of APE1
Because APEl is a multifunctional protein involved in both the repair of DNA damaged by oxidative or alkylating compoimds and in the redox regulation of a nurnber of stressinducible h·anscription factors, such as AP-1, NF-KB, HIF-lo:, and p53, it clearly plays a pivotal role between redoxsignaling that alters the cellular response to DNA damage and DNArepair functions. These transcription factors are multidomain proteins that are stntcturally unrelated, suggesting that no common structural motif is recognized by APEl. Further, the DNA-binding domains of these factors, which are redox regulated, are structurally distinct (Fig. 12) ; AP-1 is a heterodimeric bZip family protein; p53, a single immunoglobt1lin-like domain; NF-KB, a di1ner of two-domain immunoglobulin-like subunits; and HlF-la, a basic helixloop-helix domain. Redox regulation of tra115cription factors serves as one of several mechanisms that control sequencespecific DNA-binding and thereby gene expression. Of the transcription factors regulated by APEl that play an important role in the DNA-damage response or DNA-repair pathways including DR, BER, HR, MMR and GGR, p53, AP-1, and HIF-la are discussed here.
A. p53
The tumor-suppressor p53 is a sequence-specific transcription factor that serves as a potent tumor suppressor and functions in part by preserving genomic integiity (113) . Not surprisingly, it has been demonstrated that p53 promotes genomic integrity by regulating some of the DNA-repair LUO ET AL.
pathways (80, 162) . Regulation of DNA repair by p53 is complex, involving both transactivation-dependent and -independent mechanisms, revie,~red by Sengt1pta and Harris (162) , and p53 is itself regulated by both redox-dependent and -independent mechanisms involving Ref-1 (APEl).
lt1vestigation of redox regulation of p53 was initiated based on the finding that oxidized p53 bound DNA very poorly (75) and led to the discovery that Ref-1 was the factor responsible for enhancing the DNA-binding activity of '.vild-type p53 (101 ) BER is initiated by highly specialized DNA glycosylases that cleave the DNA base, creating an AP site, as discussed earlier. Regtilation of the BER path,<Vay by p53 involves both activation and negative regulation of BER enzymes under different conditions and in different cell lines. In response to yra y treatment, p53 was demonstrated to promote activation of AAG. However, this initial step in BER was also shown to be under negative transcriptional regulation by p53 after exposure to nitric oxide (NO) (202) . Recent studies demonstrated that p53 downregulated APEl expression through binding to the promoter region of APEl that includes an SPl site. APEl mRNA and protein levels decreased in a time-dependent manner in the human colorectal cancer line HCTl 16 p53( + / + ), but not in the isogenic p53-null mutant after treatment with camptothecin. Overexpression of v.rild-type p53 in the p53-null cells significantly reduced both endogenous APEl and APEl promoter-dependent luciferase expression in a dose-dependent fashion (196) . Thus, Ref-1 (APEl) regulates DNA-binding of p53, and p53 in tu1n regulates both expression and protein levels of APEl in this example.
Another BER enzyme, DNA polymerac;e P (pol fJ), involved in SP-BER, has been sho,~rn to be regttlated by p53. Pol p has associated dl~ lyase activity that is important and often rate limiting in BER and acts after APEl activity. Pol fJ also plays a role in single nucleotide gap filling in LP-BER. In p53-deficient cells, it has been sho,.vn that pol fJ protein expression is altered (35) . Additionally, pol fJ gene expression in CHO cells and HeLa cells can be upregulated by CREB in response to DNA alkylating agent exposure (79) . As discussed, CREB is under redox control for its binding to DNA and activating transc1iption. Therefore, a tight link and interaction occurs in the DNA BER process between a nurnber of transcription factors that are under redox control and the DNA-repair response ( Table 1) . NER, which is divided into TCR and CCR, as discussed earlier, is affected differentially by p53. For example, several studies fotu1d that p53 selectively affected GGR, but not TCR. T\·vo main proteins in GGR, DDB2 and XPC, "''hich are involved in DNA-damage recognition, are transcriptionally regulated by p53 (3, 96, 168) . Loss of p53 and subsequent deficiencies in the CCR proteins DDB2 and XPC appear to lead to genome instability. This has been effectively demonstrated in knockout mouse studies. In this study, lOOo/ o of xpc·I· mice develop lung cancer, and DDB2·/· mice develop skin tumors (89) . Again, if p53 is not fully functiona l through redox modification, it cannot turn on DDB2 and XPC, which would result in defective CGR (Table 1) .
MMI~, which is in charge of DNA repair after DNA polymerase errors, removes mismatches in DNA. MSH2 in complex '~1ith MSH6 or MSH3 is active in the recognition of single-base mismatches and short insertion/deletion mispairs or larger loops of unpaired nucleotides, respectively. MSH2, MLHI, and PMS2 have all been sho\.vn to be under p53 regulation, similar to DDB2 and XPC in NER (38, 159). PCNA, another member of the NER pathway, also is under p53 regulation (Table 1) (189) .
DSBs threaten severely genomic stability by facilitating deletion or translocation or both of chromosomal DNA. Because either a deficit or an excess in Hl~ may lead to genomic instability, it is not surprising that HR is highly regulated. Once again, p53 plays an important role in the repair of DSBs through the regulation of both DSB repair path\o\rays, HR and NHEJ. Increased levels of HR have been observed in mice that are deficient in wild-type p53 (26, 127) . Arias-Lopez et al. (10) demonstrated that p53 inhibits HR through repression of RAD51 expression. Additionally, p53 has been demonstrated to repress the h·anscription of the RecQ4 helicases, WRN and RecQ4 (163, 191) .
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Finally, some studies in murine fibroblast cell lines have demonstrated that AGT also is under p53 regulation (72, 155) . ACT also appears to be regulated by NF-KB, another transcription factor that is under redox control by APEl. This was demonstrated by overexpression of the p65 subunit of NF-KB in HEK293 cells, resulting in an increase in AGT expression (116) .
All of these studies point to the possible relevance of redox controlling DNA-repair responses through p53. Therefore, if reduced p53 is required to bind DNA and either activate or repress the transcription of DNA-repair genes, as discussed earlier, then it follo>vs that Ref-1 (APEI) plays an i.J.nportant role not only in the redox modulation of p53 but also in the regulation of DNA repair.
B. AP-1
Activator protein-I (AP-1) refers to a family of structurally and functionally related basic leucine zipper proteins (bZIPs) that intermix to form heterodimeric sequence-specific DNAbinding proteins, including primarily Jun proteins, c-Jnn, JunB, and JnnD, Fos proteins, c-Fos, FosB, Fra-1 and Fra-2, and some ATP-family members, ATFa, ATF-2, and ATF-3 (82). These proteins recognize AP-1 sites that are also refen·ed to as tetradecanoylphorbol-13-acetate {TPA)-responsive elements. AP-1 transcription factors are inducible factors that respond to environmental changes, including stress and radiation, or to growth-factors signals. Proliferation, differentiation, apoptosis, and transformation are some of the processes that are mediated by AP-1 (82) .
The first report of red ox activity associated with APE1 and its identification as Ref-1 resulted from efforts to identify the nuclear factor responsible for reducing AP-1 (c-Jun/c-Fos) and thereby enhancing its DNA-binding activity (1, 184) . l{edox regulation of AP-1 was found to result from oxidation/ reduction of conserved Cys residues within the basic DNAbinding domains of c-Jun and c-Fos (AP-1) (2). Oxidized AP-l shows little affinity for DNA as compared with reduced AP-1. c-Fos and c-Jun di.Jnerize through a coiled-coil interaction involving the leucine-zipper motifs and bind DNA as a heterodimer; c-Jun also forms a homodimeric species with lo,.ver DNA-binding affinity than the heterodimeric c-Jun/ c-Fos, whereas c-Fos does not exhibit any DNA-binding activity on its O\.Vn (2) . The conserved C ys residue within c-Jun is mutated to a Ser residue in the oncogenic v-Jun, ""hich is constitutively active and exhibits enhanced DNA-binding relative to c-Jun (2). Thus, Ref-1 regulates DNA binding of AP-1 in a redoxdependent manner involving direct reduction of the conserved Cys residues within the DNA-bi11ding domams of c-Jun and c-Fos. l~ef-1 has been shown to copurify wifu AP-1 (184) and thus interacts more stably ""ith this transcription factor than '.vith p53. TRX has also been identified as a factor modulating transcriptional activation of AP-1 through its reduction of Ref-1 (83) . As sttmmarized later, AP-1, which is rapidly i11duced in response to a number of cellular stimuli, regulates fue expression of several protems involved primarily in NER and MMR DNA-repail· pathways.
Tn one example of regulation of DNA-repair proteins by AP-1 composed of c-Jun and ATF2, Hayakav.ra et al. (78) identified 23 DNA-repair or repair-associated genes whose promoters are bound on phosphorylation of ATF2 and c-Jun after cisplatin treatment. These genes were identified by usi11g chromatin inununoprecipitation (ChIP) vvifu antibodies against A TF2 and c-Jun, follo,~red by hybridization to promoter arrays (78) . These include ERCCl, ERCC3, XPA, MSH2, MSH6, RAD50, RAD23B, MLHl, PMS2, UNG2, and ATM. Confirmatory studies directly established expression of some genes, including ERCCl, ERCC3, XP A, RAD23B, and MSH2, and so1ne genes that have been specifically in1plicated in fue repair of DNA-cisplatin adducts, such as RAD23B, XPA, ERCC3, XPF-ERCCl, MSH2, and PMS2. DNA adducts induced by dsplatin are repaired mainly by fue NER pafuway. Several important proteins including XI' A, I~D23B, El~CCl, and ERCC3 in NER were observed on the promoter array. The members of the MMR complex, including MSH2, MSH6, MLHl, and PMS2, which are included in a large complex involved in the recognition of DNA-cic;platin adducts, are bound strongly by activated c-Jun or ATF2 or bofu. AP-1 also was discovered to upregulate MSH2 expression i.11 the myeloid leukeinia U937 cell line treated with a phorbol ester (TPA) (95) . Undeniably, ERCCl has been recognized to be regulated by AP-1. Li et al. (119) demonstrated that AP-l is transcriptionally up-regulated ERCC-1 in response to TPA in human ovarian cancer cells (119) . All of fuese studies support fue role of fue involveinent of AP-1 in regulating a significant nu1nber of DNA-repair proteins fuat are involved mainly in fue NER and MMR pathways (Table 1 ). Because AP-1 must be converted from an oxidized to a reduced state to bind to its target sequence, redox control of thic; protein would have significant implications. As for p53, APEl is implicated as a potential poi11t of control for regulating the DNA-binding activity of AP-1 and thereby n1odulating the expression of DNA-repair protems.
C. HIF-1CJ. and hypoxia
Hypoxia-i11ducible factor -1 (HJF-1) is a heterodirneric transcription factor con1p1isrng HIF-la and HIF-1/J (also known as aryl hydrocarbon-receptor nuclear h·anslocator) LUO ET AL. subunits (93) that plays an important role under hypoxic conditions in the cell. Of fue two subunits, HIF-lCt. has been sho,.vn to be crucial for regulating cellular response to hypoxia and is frequently overexpressed in ht1man cancers. Under normal oxygen conditions, HIF-la is targeted for ubiquitinmediated proteasomal degradation by von Rippel-Landau protein (pVHL) (97, 98, 132) . Under hypoxic conditions, HIFla translocates to fue nucleus and dimerizes with HIF-1/J, forming HlF-1. HTF-1, along '"'ith coactivators, binds hypoxiaresponse elements (HREs) within promoters and regulates the expression of its downstream genes, including vascular endothelial growfu factor (VEGF) (62, 102) . The DNA-bindi11g activity of HIF-1 has been shown to be regulated by redox signali11g, and the redox-dependent stabilization of the HIF1a protein is required for activation of HIF-1 (93) . Overexpression of TRX and Ref-1 enhanced the DNA-binding activity of HJF-1, as detected in a reporter assay. The results, taken togefuer, suggest a role for I~ef-1 as a redox regulator of HIF-la. l~ef-1 (APE-1) also has been shown to be required for the binding of transc1iptional protei11s to fue HIF-1 DNArecognition element within the rat pulmonary artery endothelial cell VEGF gene (198) . Alfuough thic; study did not specifically address the role of redox regulation, fue authors found fuat l{ef-1 was required for the formation of the hypoxia-inducible transc1iptional complex, includi11g HIF-1 and transcriptional coactivators, p300 and cyclic AMP response Increasing evidence reveals fuat hypoxic stress in fue tumor microenvironment can cause genetic instability in cancer cells. Hypoxia induces changes in the expression of several genes involved in DNA-repair pathways. These shtdies suggest that hypoxia downregulates the expression of key genes '"'ithin fue MMR pathway, including MLHl and MSH2, and several critical mediators of HR, BRCAl, BRCA2, and RAD51, resulting in significant genetic instability (21, 22, 24, 25, 32, 109, 135, 138) [reviewed in Bindra et al., 2007(23) , and Bristow and Hill, 2008 (32) ]. The MMR genes appear to be repressed through a mechanism involvi11g c-Myc (25) .
In most studies, repression of MMR and HR has been sho•vn to be independent of HIF-lo: (21, 22, 24, 25, 32, 135, 138) . However, this has been contradicted by Koshiji et al. (109) , who demonstrated that HJF-la is responsible for genetic instability during hypoxia at the nucleotide level by inhibiting MSH2 and MSH6, which recognize DNA base mismatches. These investigators demonsh·ated fuat HIF-lc.< displaces fue transcriptional activator Myc fro1n Spl binding to repress MSH2-MSH6 in a p53-dependent manner (109) . HTF-1a also has been shown to be associated with the loss of MSH2 expression in human sporadic colon cancers (172) , linking hypoxia to DNA repair in fue induction of these cancers. The decrease of the expression of NBSl, a member of fue MRell-RAD50-NBS1 (MRN) complex that illitially recognizes DNA REDOX REGULATION OF DNA REPAIR DSBs, has also been shown to be HlF-la dependent (173) . These studies dei11onstrate that the regulation of DNA repair is an integral part of the hypoxic response and that hypoxia affects DNA repair partially through HTF-1a, a critical mediator in the hypoxic response ( Table 1) . As Ref-1 has been implicated in the redox regulation of HIF-la, it then aLc;o plays a role in the regulation of DNA-repair genes controlled by HIF-l o:.
VI. The Multifunctional APE1 and Redox Control
APEl is a vital multifunctional protein that acts as an essential master regulator contributing to the maintenance of the geno1ne stability (Fig. 6) . Functional activities associated with APE1 include apu1inic/ apyrimidinic endonuclease activity essential for BER, redox activity, transcriptional regulatory activity (19) , and most recently, RNA-cleavage activity (15, 176) . In this review, we have limited our discussion to the APEl BER repair and redox activities, the functions relevant to redox regulation of DNA repair. APEl also is subject to a nttmber of interesting posttranslational modifications, including acetylation, phosphorylation, and nitrosylation. The implications of these modifications \.Vere reviewed recently (19, 171) and are not further discussed here.
APEl has a pleiotropic role in controlling cellular response to oxidative stress. In addition to its repair function in BER as an AP endonuclease, APE1 controls the redox status of either ubiquitous (i.e., AP-1, Egr-1, NF-KB, p53, CREB, HIF-lo:) or tissue-specific transcription factors (i.e., PEBP-2, Pax-5 and -8, and TIF-1) (Fig. 6) (6, 35, 48, 84, 94, 112, 169, 175, 184, 185) .
ROS indticed by different oxidative or toxic agents have been shown to increase APE1 expression transiently (Fig. 13) . A number of transcription factors, including Egr-1, CREB, and Jun/ ATF4, are involved in the inducible expression of APEl (66, 73, 152) . In a recent study, the level of APEl was shown to be increased h·anscriptionally in response to ROS in melanoma cells by microphthalmia-associated transcription factor (MiTF), a key transcription factor for melanocyte lineage survival that plays an important role in development and carcinogenesis (122) . In this study, melanoma cells were classified into MiTF-positive and -negative groups to explore the function of MiTF in regulating cellular responses to ROS. IL-2) can lead to Al)El functional activation through intracellular generation of sublethal doses of ROS (170) . APEl also is directly responsible for the conh·ol of the intracellular ROS levels through inhibiting the ubiquitous sma II GTPase Rael, the regulatory subunit of NADPH oxidase system (9, 149).
Recently, Park et al. (151) found that overexpressing APEl/ I~ef-1 increased inhibition of angiotensin Il (Ang II) to the whole-cell conductance Ca 2 --activated K+ (BKca) currents in human umbilical vein endothelial cells (HUVECs) through blocking NADPH oxidase-dependent ROS production. The inhibitory effect of Ang II on BKca channel function is NADPH oxidase dependent (151) . It also was demonstrated that NADPH-mediated ROS production induced by the P2Y purinergic receptor triggering was able to promote APEl h.1nctional activation (152) and results in the proposition of an autoregulatory loop between these tl.vo systems.
We demonstrated that reducing expression of APEl in neuronal cultures by using small interfering l~A (siRNA) enhances cisplatin-induced ROS generation, cell killing, and apoptosis (103, 136) . Another recent study showed that Apel can antagonize the generation of ROS. Overexpression of APEl inhibits, ""hereas silencing APEl expression potentiates ROS accumulation under treatment with oxidative reagents or loading with granzyme K in cytotoxic T lymphocyte (CTL)/ natural killer (NK) cells. APEl is a physiological subsh·ate of granzyme K, and cleavage by granzyme K facilitates inb·acellular ROS accumulation and enhances granzyme K-induced cell death (74). Merluzzi et al. (136) also fotmd that repression of APEl by antisense overexpression determines an additional increase in CD40-mediated B-cell proliferation, and the increase is abolished by pretreatment of cells with the antioxidant N-acetyl-L-cysteine (NAC). They proposed that APEl, through control of the intracellular redox state, may also affect the cell cycle by inducing nucleus-cytoplasm redistribution of p21 (136) .
A genetic study has demonstrated that APEl is essential for cell survival and organism development. Knockout of APEl in mice leads to postimplantation embryonic lethality on days ES to E9 (188) . Conditional knockout and knockdown strategies also confirmed the crucial role of this protein in cellc; (58, 65, 99) . In addition, studies demonstrated that altering APEl levels leads to a change of cell growth, survival, and sensitivity (28, 37, 56, 58, 81, 115, 134, 147, 179, 180) . Hovvever, these studies used either overexpression of APEl, APEl antisense oligonucleotides, or APE1 siRNA to change the total amount of cellular APEl and thereby all functions of APEl, including its repair and redox activities. Thus, the function of APEl involved in each case of altered cellular function caimot be identified. Because APEl plays co1nplex and c1itical roles in cell survival, proliferation, differentiation, and apoptosis in physiologic and pathologic conditions, as '~'ell as in the gro~rth and development of the organic;m, it is important to distinguish and characterize which function of APEl is involved in different biologic events, especially those that may differ in no1mal cells and various pathologic cells, such as cancer cells. The use of specific small-molecule inhibitors blocking either repair or redox, but not both functions of APEl, ,. vi.II give a clearer picture and will be helpful for modifying its ftmcti.on in treatment of the different diseases. Our recent data demonstrated that £3330, 2E-3-[5-(2, 3 dimethoxy-6-methyl-1,4-benzoquinolyl)]-2-nonyl-2-propenoic acid]), a novel quinone derivative, specifically blocks the re-
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dox function of Al'El and has no effect on APEl-repair activity and other members of the BER pathway (128) . By using £3330, we demonstrated that APEl is required in normal embryonic hematopoiesis and that the redox function, but not repair activity, of APEl is critical in normal embryonic hematopoietic development (199) .
VII. Modulating APE1 Activities as a Cancer Therapeutic Approach
Elevated APEl levels have been demonstrated in a variety of cancers and are typically associated with aggressive proliferation, increased resistance to therapeutic agents, and poor prognosis (SO, 140, 180, 190) . Previous studies demonstrated that decreasing APEl / Ref-1 levels leads to the blockage of cell growth and the increase of cellular sensitivity to DNAdamage agents by using anti-sense oligonucleotides and sil~NA of APE1 / l~ef-1 (56, 58, 115, 147, 180) . Not yet known is the relative importance of APEl redox versus the repair function in cancer. Effo1ts to determine the effects of inhibiting either the redox or repair function of APEl are ongoing. Targeting of a specific protein, particularly one that plays an important role in cellular response to stress, by chemical knockout (i.e., through use of a small-molecule inhibitor) may have unintended consequences. However, exploration of novel targets is clearly ai1 avenue that n1erits pursuit, particularly in the case of cancers for which current treatments are ineffective. There has been considerable debate in the literature regarding the wisdom of inhibiting essential DNA-repair enzymes (14, 42, 57, 106, 129) . However, small-molecule inhibitors have been identified for several DNA-repair enzyines, including MGMT, poly ADP-ribose polymerase (PARP1), ataxia-telangiectasia mutated kinase (A TM kinase), APEl, and DNA PKcs (42, 57, 129). Targeting of the redox function of Al)El represents a novel approach iI1 the development of a cancer therapeutic agent. Blocking of the redox function of APEl would be expected to affect the activity of a number of downstream transcription factors and the gene products that they regulate. In this section, we focus primarily on redox inhibitors, those kno\.vn specifically to inhibit APEl and those that may affect APEl either directly or indirectly. We briefly discuss Al'El-repair iilhibitors as they have been reviewed recently (106) .
A. APE1 redox inhibitors 1. E3330. One molecule previously discussed '.vas demonstrated to biI1d specifically to APEl with a biI1ding constant esti.Inated by surface plasmon resonance analysis (SPR) of 1.6 nM, which suggests a specific interaction betl.veen APEl and E3330 (166) . We recently dem.onstrated that E3330 blocks the redox h.mcti.on of APEl with AP-1 as the downstream target in vitro, as well as after the treatment of ovarian cancer cells with E3330 (128) . Additionally, we found that £3330 blocks APEl redox activity ~1ith HIF-let. and other downstream transcription factors (Table 1 ) . This demonstrates that the redox inhibition is not specific for the do,.vnstream target. Although E3330 blocked the redox function of APEl, it had no effect on APEl-repair endonuclease activity. We also found that £3330 does have single-agent cancer cellkilling abilities in a variety of cancer cell lines representing ova1ian, colon, lung, breast, brain, pancreatic, prostate, and multiple myeloma cancers, but does not have significant cell killing in our studies with normal cells, such as emb1yonic hematopoiesis cells, retinal vascular endothelial cells (RVECs), and human CD34+ progenitor cells. These data implicate the redox role of APE in cancer, but not in "normal" cell survival. Inhibition of the APEl redox function significantly attenuates I~VEC proliferation and capillary formation in vitro but does not cause cell death. Furthermore, the capillary formation of RVECs appears n1uch more sensitive to redox inhibition of APEl than to the proliferation. This is the first time that this role of APEl has been clearly demonstrated. Additionally, our data demonstrate a new role of APEl in angiogenesis, and inhibition of APEl red ox function by E3330 abrogates this role (128) . E3330 also has been shown to inhibit the gro,~rth of pancreatic cancer cell lines, an effect that is enhanced under hypoxic conditions (200) , as well as pancreatic cancer-associated endothelial and endothelial progenitor cells (201) . Consistent with redox regulation by l~ef-1, the DNA-binding activity of HIF-1 is inhibited by £3330 in the aforementioned pancreatic cancer studies. TI1us, collectively our data and those of others suggest that APEl redox function will be a promising target of cancer treatment and will open a new avenue for cancer treatment.
Other redox inhibitors.
A number of natural products reported to affect either directly or indirectly the redox function of APEl in cells were recently revie~red (57, 107, 128, 133) and are therefore discussed only briefly here. Soy isoflavones, a component in soybeans, are thought to have potential as chemopreventive agents in prostate cancer (137) . Treatment of PC-3 prostate cells and xenograft mice with soy isoflavones after radiation treabnent resulted in increased cell killing, reduced NF-KB binding to DNA, and reduced APEl levels. The authors concluded that the soy isoflavones reduced APEl levels and subsequently resulted in a reduction of the ability of Al'El to reduce NF-KB, resulting in the inability of the cells to respond to the stress (156) . Ho>vever, at this point, the data are merely co1Telative.
Another nah1ral product, resveratrol, a component of red wine and grapes, was reported to affect the redox activity of APEl (193) . Resveratrol was shown to inhibit both the endonuclease activity of APEl and the DNA-binding activities of AP-1 in cellular extracts, presumably through inhibition of APEl redox function. However, this has not been corroborated by others, nor has it been shown to be effective at levels that are physiologically relevant.
B. APE1 repair inhibitors
To date, t>vo different classes of small molecules have been reported to inhibit the AP endonuclease activity of APEl, methoxyarnine (18, 124) and negatively charged molecules including CRT0044876 (130) , an aryl stibonic acid 13755 (161) , and a number of pharmacophore-based compounds (197) . Methoxyamine (MX) blocks repair by reacting with apurinic/ apyrirnidinic sites in the DNA and fom1ing stable adducts that prevent endonucleolytic cleavage by APEl (18, 64, 124) . As MX acts at the level of the DNA, it would also be expected to block the activity of other DNA-repair enzymes such as DNA polymerase f3 activity. However, none of the aforementioned co1npounds has been repo1ted to inhibit the redox activity of APEl; this is not discussed further here. A 1261 number of recent reviews discuss the status of these types of agents (14, 57, 106) .
VIII. Chemoprevention, Redox Modulation, and DNA Repair
As was clearly documented, DNA dainage leading to genome instability is a key step for the initiation and progression of cancer (16) . Both endogenous and exogenous DNA-damaging agents and particularly those that induce oxidative stress are some of the main factors that cause DNA damage in cells. Therefore, agents that reduce the oxidative stress and subsequent DNA damage, as >veil as those that increase the repair of DNA damage, are considered to be pertinent in cancer prevention. It is estimated that nearly one third of all cancer deaths in the United States could be prevented. Accumulating research evidence has shown that some dietary antioxidants are able to reduce the incidence of cancer by increasing DNA repair and reducing oxidative stress.
A. Dietary antioxidants
1. Ellagic acid. Ellagic acid, a con1ponent in berries (bh.ieberry, strawberry, and red raspberry), was reported to reduce oxidative DNA damage both in vitro and in vivo (4, 5) . In vitro, ellagic acid has demonstrated a > 95°/o inhibition of 8-oxodeoxyguosine (8-oxodG) production. It also was shown to reduce other oxidative DNA adducts caused by 4-hydroxy-17 /j-esh·adiol and CuC1 2 . In an in vivo study, female CD-1 mice were fed pure ellagic acid, and formation of DNA adducts was related to ellagic acid in a dose-dependent manner. Further srudy found both ellagic acid and its narural source resulted in overexpression of genes involved in DNA-repair pathways such as XPA, ERCC5, and DNA ligase III, mainly those involved in NER. TI1ese results demonsh·ated that ellagic acid is effective in preventing oxidative DNA damage both in vitro and in vivo by increasing DNA repair.
2. Selenium. Selenium is found in plentiful amounts in dairy, eggs, fish, meat, grains, and Brazil nuts. Selenium, in the form of selenocysteil1e, is a major constituent of many antioxidai1t enzymes known as selenoproteins. Not surprisingly, Se was reported to be preventive for cancer initiation frorn oxidative DNA damage through reducing oxidative stress and increasing DNA repair. The active species of Se include hydrogen selenide (H 2 Se) and its methylated metabolite, methylselenol (MeSeH), selenomethionine (SeMet), and selenoproteil1s. Se, in the form of selenomethionine, was reported to promote BER activity by p53 activation in normal human fibroblasts in vitro (164) . This sh1dy demonstrated that Se-induced p53 activation promotes BER activity by reducing specific cysteine residues in p53. A dominant-negative APEl redox mutant blocks reductive activation of p53 by Se. Se also was shown to stin1ulate the activity of a selenoprotein, thioredoxin reductase (TR) (165) . These data suggest that Se reduces p53 through interactions involving TR, which reduces TRX and APEl, as well as redox interactions between APEl and p53. Se-induced activation of p53 is also dependent on the BI~CAl protein in recombinational repair, which is frequently mutated in fainilial breast cancer (55). It also was reported that Se inhibited DNA-binding activity of transcription factors such as AP-1, NF-KB, SP-1, and SP-3, as '-veil as the DNA-repair proteins XPA in the NEl~ pathway and formamidopyrimidine DNA glycosylase (FPG) in the BER pathway (27, 76, 131, 195) . TI1ese data i.J.nply that Se 1nay reduce cancer incidence through modulating DNA repair, redox status of cells, and the cellular transcriptional response to oxidative stress. It also suggests that the redox function of APEl is a major component of this interaction. Additional clinical studies have found an inverse relation beh~reen the levels of Se and the prevalence of several types of cancer.
3. Oltipraz. Oltipraz (4-methyl-5-(pyrazinyl)-3H-l,2-dithiole-3-thione), a synthetic dithiolethione, is similar to the thiolethione, an antioxidant component in cruciferous vegetables. Oltipraz has been shown to inhibit the development and progression of multiple organ tumors, includi.J.1g breast, bladder, colon, sto1nach, liver, lymph nodes, h. mg, pancreas, and skin, induced by a variety of stiucturally di.verse carcinogens in preclinical studies (41 ). Clinical studies demonstrated that oltipraz has minimal toxicity in humans and significant chemopreventive activity (41). Oltipraz increased NEI~ activity by decreasing platinum-DNA adducts, but not BER activity, as 1neasured by determining the levels of AP sites in HT29 colon adenocarcinoma cells (146) . Further study found that oltipraz also increases APEl protein level and AP-1 DNA-binding, ;vhich is partially dependent on APEl in HT29 cells (194) . Oltipraz also was shown to inhibit microvessel formation in both human and rodent bioassays in a dosedependent manner (158) . These data suggest that the redox, not the repair, function of APE1 may be involved in chemopreventive effect of oltipraz.
All of these compounds are natural agents that have been i.J.nplicated in protecting against cancer.
B. Direct regulation of DNA repair by altered redox status of the cell
The evolutionarily conserved enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a key redox-sensitive protein with an active-site cysteine sulfhydryl. GAPDH was shown to interact directly with APEl (13) . By using recombinant protei.J.lS, Azam et al. (13) found thatGAPDH interacts with APEl through the active-site cysteine 152 to convert the "oxidized" form of APEl to its reduced form and reestablishes the ability to cleave AP sites. This reduction process also enhanced the detection of APEl by anti-APE! antibodies, suggesting a structural d1ange. siRNA knockdown of GAPDH in HCT116 cells enhanced sensitivity to the alkylating DNAdan1aging agent methyl methane sulfonate (.MMS), v.rhich produces AP site, and ina·eased the level of spontaneous AP sites in the genomic DNA. These data imply that GAPDH plays an i.J.nportant role in promoting BER activity by maintaining APEl, a key AP endonudease, in an active reduced state.
OGGl, an 8-oxoG DNA glycosylase in the BEI~ pathway, is responsible for recognizing and repairing 8-oxoguanine (8-oxoG), a com1non and mutagenic fo1m of oxidized guanine in DNA. A recent study 1-vith human lymphoblastoid cells treated with cadmium resulted in an almost complete reduction in the 8-oxoG DNA glycosylase activity of OGGl, presumably because of an alteration in the redox status of the cells. OGGl activity returned to normal once the redox cellular status was returned to normal. The reversible inactiva-
ti.on of OGGl activity by cadmium was strictly associated with reversible oxidation of the protein, as demonstrated by the use of cysteine-modifying agents, such as diamide, 1-vith the pure protein and cn1de extracts (30) . A frequently found polymorphism of OGG!, S326C OGGl, associated with cancer development, has been shown to have lower 8-oxoG DNA glycosylase activity, and the lower activity of OGG1-Cys326 is associated '~'ith the easy oxidation of Cys326 to form a disulfide bond (31) . Tn this study, the 8-oxoG repair activity 1-vas analyzed in the cells and cell extracts of lymphoblastoid cell lines established from individuals carrying either Ser/ Ser or Cys/ Cys genotypes. The cells homozygous for the Cys variant display increased genetic instability, reduced 8-oxoG repair rates, and almost twofold lower basal 8-oxoG DNA glycosylase activity in their cell extracts. Reducing agents increase the repair capacity to the level of the Ser va1iant, but do not affect the activity of the latter. The 8-oxoG DNA glycosylase activity in cells carryi.J.1g the Cys/ Cys alleles is more sensitive to oxidizing agents (31) .
NER, which repairs mainly bulky DNA adducts and heli.xdistorting lesions, has some crossover activity on oxidative DNA damage. On exposure of human pulmonary epithelial cell<> (A549) to nontoxic doses of H 2 0 2 , increased expression of XP A, XPC, ERCC4, and EJ~CCS was observed, whereas ERCCl expression decreased (114) . Functional studies also demonsti·ated a decrease in NER activity.
Glutathione (GSH) also is directly implicated in the regulation of NER. GSH-depletion in cells preincubated with BSO, L-buthionine-sulfoximine, completely abolished the downregulation of ERCC1 expression and the decrease in NER capacity by H 2 0 2 and increased significantly the upregulation of ERCC4 expression. These data suggest that NER capacity as well as the expression of NER-related genes can be modulated by oxidative stress (114) .
IX. Concluding Remarks
Tn conclusion, redox regulation clearly plays an important role in DNA repair, with implications for human health and cancer therapeutic development. We have highlighted the role of APEl, an important DNA-repair protein and redox factor, in this revie\·v as a protei.J.1 directly linking redox regulation and DNA repair. Tt is our expectation that future research in this area ~rill bring additional insights into the i.J.nportance of redox regulation in DNA repair and will likely result in the identification of other proteins that also play i.J.nportant roles i.J.1 redox regulation and DNA repair. 
